Table 2.
Demographics and clinical characteristics of the fistuloclysis subgroups.
| Characteristics | Group 1 (n = 11) | Group 2 (n = 16) | Group 3 (n = 8) | P value |
|---|---|---|---|---|
| Age (years) | 53.2 ± 14.1 | 48.9 ± 11.2 | 47.9 ± 13.4 | 0.346 |
| Male, n (%) | 7 (63.6) | 11 (68.8) | 5 (62.5) | 0.680 |
| BMI (kg/m2) | 20.1 ± 3.5 | 19.5 ± 2.6 | 18.8 ± 4.2 | 0.362 |
| Scores on admission | ||||
| APACHE II (24 h) | 11.0 ± 3.1 | 12.2 ± 2.7 | 11.1 ± 3.5 | 0.072 |
| SOFA (24 h) | 4.4 ± 1.2 | 4.9 ± 1.1 | 4.4 ± 1.3 | 0.060 |
| Etiology, n (%) | ||||
| Trauma | 4 (36.4) | 7 (43.8) | 3 (37.5) | 0.916 |
| Tumor | 1 (9.1) | 1 (6.3) | 1 (12.5) | 0.876 |
| Ischemic enteropathy | 1 (9.1) | 0 (0) | 0 (0) | 0.304 |
| Operations | 2 (18.2) | 6 (37.5) | 2 (25.0) | 0.527 |
| Pancreatitis | 2 (18.2) | 2 (12.5) | 1 (12.5) | 0.904 |
| IBD | 1 (9.1) | 0 (0) | 1 (12.5) | 0.272 |
| Underlying disease, n (%) | ||||
| Cancer | 1 (9.1) | 3 (18.8) | 2 (25.0) | 0.629 |
| Cardiovascular disease | 1 (9.1) | 1 (6.3) | 0 (0) | 0.563 |
| Diabetes | 1 (9.1) | 2 (12.5) | 1 (12.5) | 0.956 |
| COPD | 2 (18.2) | 2 (12.5) | 1 (12.5) | 0.908 |
| None | 7 (63.6) | 8 (50.0) | 4 (50.0) | 0.752 |
Group 1: patients with jejunal-ileal fistula; Group 2: patients with biliary fistula; Group 3: patients with duodenal fistulas. BMI: body mass index; APACHE II: acute physiology score and chronic health evaluation II; SOFA: sequential organ failure assessment score; IBD: inflammatory bowel disease; COPD: chronic obstructive pulmonary disease. Data were presented as mean ± SD. P value < 0.05 was deemed significant.